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background
 
There are few epidemiologic data on invasive bacterial infections among children in
sub-Saharan Africa. We studied every acute pediatric admission to a rural district hospi-
tal in Kenya to examine the prevalence, incidence, types, and outcome of communi-
ty-acquired bacteremia.
 
methods
 
Between August 1998 and July 2002, we cultured blood on admission from 19,339 in-
patients and calculated the incidence of bacteremia on the basis of the population served
by the hospital.
 
results
 
Of a total of 1783 infants who were under 60 days old, 228 had bacteremia (12.8 per-
cent), as did 866 of 14,787 children who were 60 or more days of age (5.9 percent).
Among infants who were under 60 days old, 
 
Escherichia coli
 
 and group B streptococci
predominated among a broad range of isolates (14 percent and 11 percent, respectively).
Among infants who were 60 or more days of age, 
 
Streptococcus pneumoniae,
 
 nontyphoidal
salmonella species, 
 
Haemophilus influenzae,
 
 and 
 
E. coli
 
 accounted for more than 70 percent
of isolates. The minimal annual incidence of community-acquired bacteremia was es-
timated at 1457 cases per 100,000 children among infants under a year old, 1080
among children under 2 years, and 505 among children under 5 years. Of all in-hospital
deaths, 26 percent were in children with community-acquired bacteremia. Of 308 deaths
in children with bacteremia, 103 (33.4 percent) occurred on the day of admission and
217 (70.5 percent) within two days.
 
conclusions
 
Community-acquired bacteremia is a major cause of death among children at a rural
sub-Saharan district hospital, a finding that highlights the need for prevention and for
overcoming the political and financial barriers to widespread use of existing vaccines
for bacterial diseases.
abstract
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ach year in sub-saharan africa,
 
4.6 million children die before reaching
the age of five years,
 
1
 
 and the vast major-
ity of these deaths are not fully investigated. Most
health facilities lack the resources for doing micro-
biologic studies, so the data on invasive bacterial
infections are very limited. The local incidence of
infections such as meningitis and pneumonia has
been estimated, often in relation to vaccine stud-
ies.
 
2
 
 However, there are almost no estimates of in-
cidence, mortality, or hospital burden for the ma-
jority of pathogenic bacterial species. Most data are
from a few urban referral centers,
 
3-9
 
 with very little
recent data from the rural areas
 
10,11
 
 where most
people in sub-Saharan Africa live. Thus, the impact
of childhood bacteremia is largely unknown. We
aimed to establish a complete description of com-
munity-acquired bacteremia among children admit-
ted to a rural Kenyan district hospital by investigat-
ing all acute admissions, without selection. We
sought to determine the burden, incidence, and
types of community-acquired bacteremia and the
associated mortality. We also examined the associ-
ation between bacteremia and two prevalent coex-
isting illnesses, malnutrition and infection by the
human immunodeficiency virus (HIV). We report
the results of a prospective study of 19,339 chil-
dren during four years.
 
location
 
Kilifi District Hospital is situated in a rural area on
the Kenyan coast (Fig. 1). Children living in the
district receive 10 to 100 mosquito bites infective
for 
 
Plasmodium falciparum
 
 annually. Primary care fa-
cilities in the district are limited. Antibiotics and
antimalarial drugs, including a combination of sul-
famethoxazole and pyrimethamine, are available
without prescription. Immunization with 
 
Haemoph-
ilus influenzae
 
 type b conjugate vaccine was intro-
duced in November 2001. In 2000, 9.8 percent of
women attending the hospital antenatal clinic were
infected with HIV.
 
12
 
 Antiretroviral therapy was not
in use during the study. Government-employed clin-
ical officers in the outpatient department, working
independently of the inpatient research team, re-
ferred children for admission.
 
patients and clinical methods
 
We recruited all children under the age of 13 years
who were admitted to the hospital between Au-
gust 1, 1998, and July 31, 2002, unless they were
admitted for elective procedures or for observation
after minor accidents. The study was explained to
the parent or guardian of each child, and written in-
formed consent was obtained. The Kenya Medical
Research Institute/National Ethical Review Com-
mittee approved the study. Data were recorded on
admission on standard forms.
 
13
 
 We defined young
infants as those under 60 days old.
 
14
 
 Weight was
measured with the use of an electronic scale (Wey-
lux), which was checked weekly for accuracy and
consistency. We calculated z scores for weight ac-
cording to age using American National Center for
Health Statistics reference data (Epi Info, version
6.01). Malnutrition was defined as a weight-for-
age z score of ¡3 or less or the presence of bilateral
pedal edema (kwashiorkor). Patients with severe
medical problems were defined as those who were
admitted to the intensive care unit. (The intensive
care unit was not equipped with mechanical venti-
lators.) Antibiotics and other treatments were giv-
en according to recommendations of the World
Health Organization (WHO)
 
4
 
 and were subsequent-
ly modified by clinical response and laboratory re-
sults. Research clinicians provided around-the-clock
clinical care.
 
sampling and laboratory methods
 
On admission, the child’s skin was cleaned with
70 percent ethanol and allowed to dry before blood
was drawn for culture, a complete blood count
(Beckman Coulter), malaria testing, HIV serolog-
ic testing, and antimicrobial testing. Blood was
inoculated into a culture bottle (BACTEC Peds
Plus, Becton Dickinson) after the needle had been
changed and the top had been cleaned with 70 per-
cent ethanol and allowed to dry. Blood culture bot-
tles were weighed before and after inoculation and
processed with an automated blood-culture sys-
tem (BACTEC 9050, Becton Dickinson). Positive
blood and cerebrospinal fluid samples were cul-
tured on standard mediums with the use of routine
microbiologic techniques. A biochemical test kit
(API, Biomerieux), serologic tests, or both were used
to confirm suspected pathogens. Pneumococcal
serotyping was performed with the use of the quel-
lung reaction and 
 
H. influenzae
 
 serotyping by latex
agglutination using polyclonal rabbit antiserum
(Statens Seruminstitut and Difco Laboratories). The
results of 
 
H. influenzae
 
 serotyping were confirmed
by polymerase-chain-reaction (PCR)–based capsu-
lar genotyping with the use of primers designed to
e
methods
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amplify the capsule type-specific regions of the cap
loci in each of the six capsular 
 
H. influenzae
 
 types
a through f.
 
15
 
Antibodies to HIV were tested by enzyme-linked
immunosorbent assay (ELISA) (Vironostika, Bio-
merieux) and dipstick (Determine, Abbott Labora-
tories). Positive samples from children under 18
months of age and samples with discordant re-
sults were assayed by PCR for proviral DNA.
 
16
 
 Anti-
microbial activity in plasma was determined with
the use of a bioassay in which a filter paper disk con-
taining 20 µl of plasma was placed on a fully sensi-
tive strain of 
 
Staphylococcus aureus
 
 (NCTC6571) on a
nutrient agar plate, incubated overnight at 37°C, and
examined for a zone of inhibition, indicating anti-
microbial activity. All laboratory procedures were
internally controlled, and external quality monitor-
ing was performed by the United Kingdom Nation-
al External Quality Assessment Service.
 
population of catchment area 
 
In 2000, a demographic surveillance system was
established to monitor a population of 189,148 peo-
ple living in 23,549 households in an area of 706
km
 
2
 
 surrounding the hospital. Approximately 15
percent of births in the area occurred in Kilifi Dis-
trict Hospital. Using data from 2000 to 2003, we
extrapolated age-specific population estimates to
the midpoint of the study, accounting for the rates
of birth, death, and migration. Incidence estimates
were calculated with the use of data from patients
with bacteremia who were residing within the sur-
veillance area.
 
statistical analysis
 
Data analysis was performed with the use of Stata
software (version 8.0). Categorical data were test-
ed with Fisher’s exact test and the chi-square test
for trend. We used the Kruskal–Wallis test to com-
pare the distributions of nonordinal data. Report-
ed P values are two-tailed. We used logistic regres-
sion, adjusted for age, to examine the deaths of
inpatients with potentially contaminated blood cul-
tures. The effect on culture sensitivity of antimicro-
bial agents in the blood was estimated with the use
of a case–control study among infants who were at
least 60 days old and resided within the surveillance
area. The 556 controls were randomly selected from
among 15,476 patients who did not have bactere-
mia and were matched by age in two strata of the
study group (2 to 17 months and 18 months or
more) and by the severity of their illness (fatal, se-
vere, or nonsevere) with 499 patients with bactere-
mia. We calculated the prevalence of antimicrobial
use as a weighted average between strata and ex-
pressed the effects of antimicrobial drugs on cul-
ture positivity as odds ratios with 95 percent confi-
dence intervals, using Cornfield’s approximation.
 
17
 
To evaluate the association between bactere-
mia and HIV infection, stored plasma samples from
1044 patients with bacteremia and 1037 randomly
selected patients who did not have bacteremia, fre-
quency-matched for age in three strata (0 to 59 days,
2 to 17 months, and 18 months or more), were test-
ed for HIV. We analyzed these data, including in-
dividual anthropometric measurements, using lo-
gistic regression with adjustment for age.
During the study, 20,340 children were admitted
to the hospital. We excluded 744 children who had
nonacute medical problems (those admitted for
elective procedures or for observation only), 90 who
were admitted for acute medical problems but
whose parent or guardian did not provide parental
consent for participation in the study, 138 for whom
blood cultures were not available, and 29 with in-
adequate records. Thus, 19,339 patients (98.7 per-
cent of patients with acute medical problems) were
included. Blood cultures from 2769 of those patients
(14.3 percent) grew coagulase-negative staphylo-
cocci (1526 patients), bacillus (1162), micrococcus
(52), or viridans streptococci (29). The propor-
tion of patients with these isolates who died in the
results
 
Figure 1. Map Showing the Location of Kilifi in a Rural Area on the Kenyan 
Coast.
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hospital was similar to that of all other admis-
sions (age-adjusted odds ratio, 1.11; 95 percent
confidence interval, 0.96 to 1.29). These isolates
were classified as contaminants, and since they may
have masked a true infection, these patients were
excluded from the analysis. Data from 16,570 pa-
tients with acute medical problems who had blood
cultures that were definitely positive or negative
were therefore entered into the main analysis. Of
these patients, 14,518 were under the age of five
years (87.6 percent), 2676 were admitted to the in-
tensive care unit (16.1 percent), and 1184 died in
the hospital (7.1 percent).
 
prevalence of community-acquired 
bacteremia
 
Of the 16,570 patients whose results were ana-
lyzed, bacteremia was identified in 1094 (6.6 per-
cent) (Table 1). Bacteremia occurred in 608 of 8945
boys (6.8 percent) and in 486 of 7625 girls (6.4 per-
cent) (P = 0.27). There was no evidence of variation
in the overall prevalence of bacteremia according
to age for patients who were more than a year old.
Among infants admitted on the first day of life, 21
of 260 (8.1 percent) had bacteremia, as compared
with 96 of 607 (15.8 percent) admitted on day 2 to
day 6 (P=0.002). During the study, lumbar punc-
ture was performed in 3810 children (23.0 percent),
and cerebrospinal fluid cultures yielded an addi-
tional 22 isolates that were not identified by blood
culture. The results of those cultures are not in-
cluded here.
The median volumes of blood that were cul-
tured were 1.2 ml (interquartile range, 0.6 to 1.9)
among patients who were at least 60 days old and
0.6 ml (interquartile range, 0.2 to 1.3) among
younger infants. The median volumes that were
cultured among children at least 60 days old were
1.1 ml among patients with fatal illness, 1.3 ml
among those with severe illness, and 1.2 ml among
those with medical problems that were not severe
(P<0.001). Among children who were at least 60
days old, the proportion who had a positive blood
culture increased with each milliliter of blood that
was cultured (5.6 percent at 1 ml, 6.8 percent at
2 ml, and 7.9 percent at 3 ml; P=0.006). There was
no significant trend among younger children. The
proportions of all children with antimicrobial ac-
tivity in plasma were 11.0 percent for those with fa-
tal illness, 8.6 percent for those with severe illness,
and 3.5 percent for those with nonsevere medical
problems. Plasma antimicrobial activity was signif-
icantly associated with bacteremia both in patients
who died (odds ratio, 0.38; 95 percent confidence
interval, 0.15 to 0.98) and in those who had severe
illness (odds ratio, 0.27; 95 percent confidence in-
terval, 0.08 to 0.92) but not in those with nonacute
medical problems.
 
types of bacteremia
 
A single organism was isolated from each of 1057
cultures obtained on admission, two organisms
were isolated from each of 36 cultures, and three
organisms were isolated from 1 culture. Thus, 1132
organisms were isolated from 1094 admission
blood cultures (Table 2).
Among children who were at least 60 days of
age, 
 
Streptococcus pneumoniae,
 
 nontyphoidal salmo-
nella, 
 
H. influenzae,
 
 and 
 
Escherichia coli
 
 accounted for
more than 70 percent of isolates. The proportion
of the cases of bacteremia that were caused by either
 
S. pneumoniae
 
 or 
 
S. aureus
 
 increased with each year
 
* CI denotes confidence interval.
 
Table 1. Prevalence and Outcome of Community-Acquired Bacteremia among Hospitalized Children, According to Age.*
Age
All
Patients
Patients with 
Bacteremia
Patients without 
Bacteremia
Patients with
Bacteremia
(95% CI)
Deaths Involving
Bacteremia
(95% CI)
 
Total Deaths Total Deaths
 
percent
 
<7 days 867 117 65 750 247 13.5 (11.5–16.0) 20.8 (16.5–25.8)
7–59 days 916 111 29 805 51 12.1 (10.1–14.4) 36.2 (25.8–47.8)
60–364 days 4,354 301 86 4,053 152 6.9 (6.2–7.7) 36.1 (30.0–42.5)
≥1 yr 10,433 565 128 9,868 426 5.4 (5.0–5.8) 23.1 (19.7–26.8)
All ages 16,570 1094 308 15,476 876 6.6 (6.2–7.0) 26.0 (23.5–28.6)
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of age. 
 
S. pneumoniae 
 
was found in 26 percent of pa-
tients who were 12 to 23 months old and in 49 per-
cent of patients who were more than 5 years old.
 
S. aureus
 
 was found in 3 percent of patients who
were 12 to 23 months old and in 14 percent of pa-
tients who were more than 5 years old (P<0.001).
The proportion of patients with nontyphoidal sal-
monella declined from 23 percent among those
who were 12 to 23 months old to 7 percent among
those who were more than 5 years old (P<0.001).
 
H. influenzae
 
 continued to account for 11 percent of
isolates in patients who were at least five years old.
In infants under 60 days of age, the most common
bacterial species were 
 
E. coli
 
 (in 13.7 percent of iso-
lates), group B streptococci (in 10.8 percent), and
acinetobacter species (in 10.4 percent) (Table 2).
Pneumococci, 
 
S. aureus,
 
 group A streptococci, and
klebsiella species each accounted for approximate-
ly 8 percent of isolates in young infants.
Two isolates of 
 
S. pneumoniae
 
 and one of 
 
H. influ-
enzae
 
 could not be propagated in culture for serotyp-
ing. The most common pneumococcal serotypes
were 1 (in 66 patients), 14 (in 39), 6A (in 26), 6B (in
24), 23F (in 21), 18C (in 13), 4 (in 11), 3 (in 10), and
19F (in 10). Of 18 isolates from young infants, 11
were of serotypes contained in the 9-valent conju-
gate pneumococcal vaccine (61.1 percent); of 262
isolates from older children, 185 were of serotypes
contained in the pneumococcal vaccine (70.6 per-
cent).
 
18
 
 Among isolates of 
 
H. influenzae
 
, 113 of 136
were serotype b (83.0 percent), including 5 of 8 iso-
lates from young infants; 15 isolates could not be
typed (11.2 percent), 5 were serotype f, and 2 were
serotype a.
 
incidence of community-acquired 
bacteremia
 
The minimal incidence of community-acquired bac-
teremia was 1457 cases per 100,000 children per
year for children under one year of age, 1080 per
100,000 per year for those under two years, and 505
per 100,000 per year for those under five years (Ta-
ble 3). The minimal rate of neonatal bacteremia
was 5.46 cases per 1000 live births. For comparison,
 
* Percentages refer to the proportion of the isolates in each age group. Percentages may not sum to 100 because of rounding.
† Species included streptococci groups D (27 patients), C (3), and G (6).
‡ Species included enterobacter (22 patients), aeromonas (13), campylobacter (9), citrobacter (7), 
 
Proteus mirabilis
 
 (7), 
shigella (6), and neisseria (5).
 
§ Since polymicrobial bacteremia was identified in 37 patients, the number of isolates exceeds the number of patients.
 
Table 2. Bacterial Species Isolated from 1094 Patients with Bacteremia.
Pathogen Age
Rank of 
Incidence
 
<7 Days 7–59 Days 60–364 Days ≥1 Yr
Total 
(All Ages)
 
number of isolates (percent)*
 
Gram-positive
 
Streptococcus pneumoniae
 
5 (4) 14 (12) 63 (20) 200 (34) 282 1
 
Staphylococcus aureus
 
7 (5) 13 (12) 17 (5) 41 (7) 78 5
Group A streptococci 3 (2) 17 (15) 10 (3) 18 (3) 48 7
Group B streptococci 11 (9) 15 (13) 0 2 (<1) 28 10
Other† 11 (9) 3 (3) 11 (4) 11 (2) 36 —
 
Gram-negative
 
Nontyphoidal salmonella species 1 (<1) 4 (4) 56 (18) 105 (18) 166 2
 
Haemophilus influenzae
 
1 (<1) 7 (6) 62 (20) 66 (11) 136 3
 
Escherichia coli
 
25 (19) 8 (7) 41 (13) 47 (8) 121 4
Acinetobacter species 16 (12) 9 (8) 16 (5) 30 (5) 71 6
Pseudomonas species 6 (5) 3 (3) 15 (5) 15 (3) 39 8
Klebsiella species 13 (10) 7 (6) 7 (2) 9 (2) 36 9
Other‡ 30 (23) 12 (11) 12 (4) 37 (6) 91 —
Total 129 112 310 581 1132§
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among children under the age of five years, the in-
cidence of admission to the hospital with a diagno-
sis of malaria was 3893 admissions per 100,000
per year, and the incidence of admission with a di-
agnosis of gastroenteritis was 2057 per 100,000
per year.
 
hiv infection and malnutrition
 
HIV infection was present in 186 of 1044 patients
with bacteremia (17.8 percent) and in 57 of 1037
patients who did not have bacteremia (5.5 percent)
(P<0.001). Severe malnutrition was present in 410
of 1094 patients with bacteremia (37.5 percent)
and in 3341 of 15,476 patients who did not have
bacteremia (21.6 percent) (P<0.001). Both HIV in-
fection and malnutrition were independently asso-
ciated with bacteremia (Table 4). There was no evi-
dence of an interaction between the effects of HIV
infection and malnutrition on bacteremia (P=0.36).
 
inpatient mortality
 
Of a total of 1094 patients who had bacteremia,
308 died (28.2 percent), as compared with 876 of
15,476 patients who did not have bacteremia (5.7
percent) (P<0.001). The case fatality rate did not
vary significantly among the bacterial isolates. Over-
all, 308 of all 1184 inpatient deaths (26.0 percent)
were associated with bacteremia (Table 1). For com-
parison, 258 deaths (21.8 percent) were associated
with 
 
P. falciparum
 
 parasitemia. Of those deaths, 53
were in infants and children with bacteremia (20.5
percent).
Deaths in children with bacteremia were rapid:
103 of 308 deaths occurred on the day of admission
(33.4 percent), 79 occurred the next day (25.6 per-
cent), and 35 occurred on day 3 (11.4 percent). The
predominant isolates among children who died on
the day of admission were 
 
S. pneumoniae
 
 (49 percent)
and 
 
H. influenzae
 
 (19 percent) in patients who were
at least 60 days old and group B streptococci (13
percent), 
 
E. coli
 
 (11 percent), and klebsiella species
(11 percent) in younger children.
The stimulus for this study was the observation that
inpatient deaths in Kilifi usually occurred after a fe-
brile illness. Although the area has a high rate of
malaria, the disease was associated with less than
a quarter of the deaths,
 
19
 
 and there were few data on
other causes. We found that community-acquired
bacteremia was responsible for at least one third of
deaths in infants and one quarter of deaths in chil-
dren over one year of age.
Several factors suggest that our incidence fig-
ures considerably underestimate the actual inci-
dence of bacterial sepsis. First, it is well established
that blood cultures are insensitive for detecting
bacteremia. In a series of 815 children with clinical-
ly defined sepsis in Latin America, only 26 percent
discussion
 
* Person-years of observation are shown for patients under the age of one year, two years, and five years, calculated as the 
 
midstudy population multiplied by four years.
 
Table 3. Estimated Minimal Incidence of Bacteremia in the Catchment Area of Kilifi District Hospital, According to Age.
Pathogen Incidence of Bacteremia*
 
<28 Days Old
(N=27,284 Births)
<1 Yr Old
(N=26,968
Person-Yr)
<2 Yr Old
(N=50,804
Person-Yr)
<5 Yr Old
(N=136,444
Person-Yr)
 
no./1000 live 
births/year no./100,000 children/year
 
Any organism 5.46 1457 1080 505
 
Streptococcus pneumoniae
 
0.37 241 213 111
 
Staphylococcus aureus
 
0.44 89 57 27
Group A streptococci 0.55 96 63 29
Group B streptococci 0.66 74 39 15
Nontyphoidal salmonella species 0.07 170 175 88
 
Haemophilus influenzae
 
0.07 159 120 60
 
Escherichia coli
 
0.81 204 136 54
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were found to have positive blood cultures, although
the mortality among the children who had positive
blood cultures was equivalent to that among the
children who had negative cultures.
 
20
 
 In neonates
with septicemia, the incidence of group B strepto-
coccal infection may be underestimated by more
than 50 percent if positive cultures from sites other
than blood are not considered.
 
21
 
Small volumes of inoculation and the use of an-
tibiotics may compromise the sensitivity of blood
cultures.
 
22
 
 We found that the sensitivity of blood
cultures fell by almost one third when cultured sam-
ples of 1 ml were compared with those of 3 ml. Re-
cent antibiotic use reduced blood-culture yields by
62 to 73 percent in patients with severe or fatal dis-
ease. Ten percent of such patients had evidence of
recent antibiotic use, but it is likely that many more
patients had been exposed to antibiotics in the few
days preceding admission. Children who died dur-
ing the study had the lowest-volume blood samples
for culture and the greatest rate of antibiotic use
and were therefore the most susceptible to these
types of underascertainment.
Second, in common with most rural areas of
sub-Saharan Africa, 66 percent of deaths of chil-
dren between the ages of three months and five
years in our surveillance area occur outside hos-
pitals (unpublished data). It is quite conceivable,
therefore, that the true community-based incidence
of bacteremia is at least twice the rate that we ob-
served. For all of these reasons, there is likely to have
been a large burden of undetected bacteremia with
additional attributable mortality. Seen in this con-
text, our findings suggest that invasive bacterial in-
fection is the principal immediate cause of death
among children admitted to Kilifi District Hospi-
tal and makes a significant contribution to com-
munity-based mortality among children in this ru-
ral, sub-Saharan district.
In children who were at least 60 days of age,
 
S. pneumoniae
 
 and nontyphoidal salmonella species
were the predominant isolates, supporting results
from other African series.
 
3,4,7,9-11
 
 We found only
three cases of 
 
Neisseria meningitidis
 
 and one case of
 
Salmonella typhi
 
 bacteremia. 
 
H. influenzae
 
 type b con-
jugate vaccination was introduced in the final eight
months of the study. We did not observe any effect
within this period and believe that our results ac-
curately reflect the prevaccination era. Our findings
in young infants appear to differ from those of
the WHO multicenter study,
 
23
 
 which reported that
 
S. pneumoniae, S. aureus,
 
 and group A streptococci
predominated and that group B streptococcal in-
fections were uncommon. We found that group B
streptococcal bacteremia was the leading bacteri-
al cause of early death in young infants. This differ-
ence in findings partly reflects the designs of the two
studies: the WHO study included only infants who
were under three months of age, of whom 8 percent
were recruited during the first week of life; of the
patients in our study who were under three months
of age, 40 percent (867 of 2172) were less than a
week old. The prevalence of HIV infection among
women attending the hospital antenatal clinic (9.8
percent) is close to the World Bank’s overall esti-
mate of 9.3 percent for sub-Saharan Africa in 2001.
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Our findings are likely to reflect the situation in the
region as a whole. Although HIV infection was an
important risk factor, 82 percent of the patients in
our study who had community-acquired bacteremia
were not infected with HIV.
The considerable mortality associated with com-
munity-acquired bacteremia and the short interval
between admission and death, despite careful im-
plementation of the WHO recommendations for
treatment, highlight the need for prevention. Even
where microbiologic facilities exist, causative or-
ganisms can be identified only after 24 to 48 hours,
by which time most deaths in children with bacte-
remia have already occurred.
In countries in which 
 
H. influenzae
 
 type b and
 
* Odds ratios are for the presence or absence of bacteremia, adjusted for age, 
HIV infection, and malnutrition.
† Data regarding the status of infection with HIV were missing for 50 patients 
with bacteremia (4.6%), so only 1044 patients were included in the analysis.
‡ A total of 1037 patients were randomly selected and matched by age and by 
the severity of their illness to patients with bacteremia.
§ HIV infection was not detected in any patients with group B streptococcal bac-
 
teremia.
 
Table 4. Odds Ratio for Community-Acquired Bacteremia in Children 
with Malnutrition and Those with HIV Infection.
Pathogen Odds Ratio (95% Confidence Interval)*
 
Malnutrition HIV Infection†
None‡ 1.00 1.00
Any organism 2.02 (1.65–2.47) 3.22 (2.34–4.44)
 
Streptococcus pneumoniae
 
1.85 (1.36–2.52) 5.84 (3.98–8.56)
 
Staphylococcus aureus
 
1.31 (0.76–2.26) 1.93 (0.87–4.27)
Group A streptococci 3.28 (1.75–6.15) 2.24 (0.82–6.14)
Group B streptococci§ 1.15 (0.45–3.00) —
Nontyphoidal salmonella species 1.68 (1.15–2.44) 3.21 (1.95–5.28)
 
Haemophilus influenzae
 
1.16 (0.75–1.79) 2.97 (1.71–5.17)
 
Escherichia coli
 
4.73 (3.15–7.10) 2.24 (1.19–4.22)
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pneumococcal conjugate vaccines have been in-
troduced in infancy, there has been a dramatic re-
duction in severe illness caused by these organ-
isms.
 
18,25,26
 
 With the support of the Global Alliance
for Vaccines and Immunization, seven African coun-
tries had introduced 
 
H. influenzae
 
 type b conjugate
vaccine into routine immunization services by De-
cember 2003. Conjugate pneumococcal vaccine has
not been used in Africa except in efficacy trials, al-
though the Pneumococcal Vaccines Accelerated
Development and Introduction Plan is working to
establish pneumococcal surveillance and promote
vaccination.
We believe that the principal reason for the
failure to prioritize the introduction of available
vaccines is the widespread perception that these
diseases have only marginal significance in public
health. For instance, invasive bacterial infection
does not specifically appear on the basic lists pro-
duced by the WHO and other agencies regarding
the major causes of death in children in sub-Sahar-
an Africa (i.e., malnutrition, acute respiratory in-
fection, diarrhea, malaria, measles, HIV infection,
and perinatal conditions).
 
1,27
 
The WHO estimates that 77 percent of the 4.6
million deaths
 
1
 
 in children under the age of five
years in sub-Saharan Africa each year are nonperi-
natal.
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 In this study, 4.9 percent of hospital deaths
in children between the ages of 60 days and 5 years
were attributable to 
 
H. influenzae
 
 bacteremia, and
8.7 percent to 
 
S. pneumoniae
 
 bacteremia. If these pro-
portions were extrapolated across sub-Saharan
Africa to include all children under the age of five
years, these two organisms would account for a min-
imum of 482,000 annual deaths, the majority of
which could be prevented with the use of available
vaccines. Although this study provides evidence of
an enormous potential benefit of existing bacteri-
al vaccines, there are no corresponding published
studies of costs or cost–benefit ratios in this setting.
Overcoming the political and financial barriers to
widespread implementation of existing vaccines
and developing new vaccines against other com-
mon bacterial pathogens are among the most ur-
gent priorities for increasing the survival of children
in sub-Saharan Africa.
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